课题基金 / 基金详情

The prostate stem cell is a target of vitamin D chemoprevention

The prostate stem cell is a target of vitamin D chemoprevention
前列腺干细胞是维生素 D 化学预防的目标
批准号:
8326107
负责人:
Scott D Cramer
金额:
$30.28万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-06 至 2015-05-31

项目摘要

项目成果

Scott D Cramer的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):循环维生素D水平与前列腺癌风险呈负相关,已经提出补充维生素D以预防前列腺癌。我们最近建立了一种成年前列腺祖细胞/干细胞(PrP/SC)小鼠模型。成体组织特异性干细胞可能是化学预防的重要靶点。我们研究了维生素D的活性代谢物,1,25 -二羟基维生素D3 [1,25(OH)2D3]对PrP/SC的影响。1,25(OH)2D3阻断增殖,诱导细胞周期阻滞,并增加周期蛋白依赖性激酶抑制剂p21和p27的表达。我们的数据表明,1,25(OH)2D3促进PrP/SC的分化。与前分化一致,我们观察到1,25(OH) 2d3处理的PrP/SC中雄激素受体(AR)表达增加。为了确定维生素D受体转录活性的新靶点并评估整体基因表达变化,我们使用1,25(OH) 2d3处理的PrP/SC的RNA探测基因表达阵列。我们发现了一个信号通路,该信号通路对于125 (OH)2D3对PrP/SC的抗增殖作用是必要和充分的,并且是诱导AR所必需的。初步数据还表明,适度的细胞周期阻滞和更深刻的衰老诱导依赖于该通路。该项目将更详细地探讨前列腺干细胞中维生素D信号通路的作用。我们将评估维生素D的调节机制以及该途径如何与AR信号通路相交,我们将确定体外和体内维生素D导致衰老的信号通路,我们将在前列腺癌遗传模型中测试维生素D阻止前列腺肿瘤进展的能力,该模型以p27依赖的方式通过前列腺上皮内瘤变进展。总的来说,这些研究将影响我们对维生素D信号在前列腺干细胞生长停滞、分化和衰老中的作用的理解,以及维生素D在预防前列腺肿瘤进展中的功能作用。
英文摘要
DESCRIPTION (provided by applicant): Circulating vitamin D levels are inversely associated with prostate cancer risk and supplementation with vitamin D for prostate cancer prevention has been proposed. We recently developed a mouse model of adult prostate progenitor/stem cells (PrP/SC). The adult tissue specific stem cell may be an important target for chemoprevention. We have interrogated the effects of the active metabolite of vitamin D, 1a,25-dihydroxyvitamin D3 [1,25(OH)2D3], on the PrP/SC. 1,25(OH)2D3 blocks proliferation, induces cell cycle arrest, and increases expression of cyclin-dependent kinase inhibitors p21 and p27. Our data suggest that 1,25(OH)2D3 promotes differentiation of the PrP/SC. Consistent with prodifferentiation we observe increased androgen receptor (AR) expression in 1,25(OH)2D3-treated PrP/SC. To identify novel targets of vitamin D receptor transcriptional activity and to assess global gene expression changes we probed gene expression arrays with RNA from 1,25(OH)2D3-treated PrP/SC. We identified a signaling pathway that is both necessary and sufficient for 1,25(OH)2D3 antiproliferative actions on the PrP/SC and is required for induction of AR. Preliminary data also demonstrate a moderate cell cycle block and a more profound induction of senescence, which is dependent on this pathway. This project will interrogate the role of this pathway in vitamin D signaling in the prostate stem cell in more detail. We will evaluate the mechanism of regulation by vitamin D and how this pathway intersects with AR signaling, we will determine the signaling pathway leading to senescence in response to vitamin D both in vitro and in vivo, and we will test the ability of vitamin D to block prostate tumor progression in a genetic model of prostate cancer that exhibits progression through prostatic intraepithelial neoplasia in a p27-dependent manner. Overall these studies will impact our understanding of the effects of vitamin D signaling on prostate stem cell growth arrest, differentiation and senescence and the functional roles of vitamin D in the prevention of prostate tumor progression. PUBLIC HEALTH RELEVANCE: Prostate cancer is a significant health problem in the US which is a candidate disease for chemoprevention strategies. This project will dissect the underlying mechanisms of vitamin D-induced changes on the prostate stem cell, a viable target for chemoprevention strategies. This project will further our efforts to develop rationale chemoprevention strategies for prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
  • 批准号:
    10657393
  • 项目类别:
  • 资助金额:
    $38.41万
  • 财政年份:
    2021
  • 负责人:
    Scott D Cramer
  • 依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
  • 批准号:
    10276486
  • 项目类别:
  • 资助金额:
    $39.19万
  • 财政年份:
    2021
  • 负责人:
    Scott D Cramer
  • 依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
  • 批准号:
    10439892
  • 项目类别:
  • 资助金额:
    $38.41万
  • 财政年份:
    2021
  • 负责人:
    Scott D Cramer
  • 依托单位:
Training Program in Cancer Biology
  • 批准号:
    10332080
  • 项目类别:
  • 资助金额:
    $25.18万
  • 财政年份:
    2016
  • 负责人:
    Scott D Cramer
  • 依托单位:
海外基金